[ad_1]
Regular use of badgesics could dramatically improve cancer treatment, according to research.
Aspirin and ibuprofen increased survival rates from 25% to 78% of head and neck tumors.
One-third of cancers, which kill 4,000 Britons a year, alter the PIK3CA gene.
The University of California at San Francisco has discovered a "powerful clinical benefit" of painkillers to treat the mutation.
In their article in the Journal of Experimental Medicine, the authors stated that it was the first study to show a "strong clinical benefit" from regular use of NSAIDs for patients with head and neck cancer with PIK3CA gene mutations.
POLAR GEL
The UK will cover 13-inch snow while the Arctic explosion will sweep next week
STEADY JOB
Mom, 27, nicknamed "Sheath Queen", makes live penises for cleaning horses at the rate of £ 25 per shot
TRIPLE TRAGEDY
Mom, 27, has committed suicide and her 1 and 3 year old daughters in a murder-suicide tragedy
Dr. Jennifer Grandis, Professor of Head and Neck Surgery and Lead Author of the article, said, "Our findings suggest that the use of NSAIDs could significantly improve outcomes for patients. patients with head and neck cancer, but also for patients contained the mutation PIK3CA.
"The magnitude of the apparent benefit is strong and could potentially have a positive impact on human health."
[ad_2]
Source link